Chief Executive Officer and Executive Director
Martin joined Realm Therapeutics in June 2015 as Chief Executive Officer (CEO) and Executive Director. He serves on the Audit Committee. He brings more than 25 years of experience having held senior positions in both private and public companies principally in the pharmaceutical and biopharmaceutical industry. He previously served as a CEO of Affectis Pharmaceuticals AG, Chief Operating Officer of Intercept Pharmaceuticals (Nasdaq: ICPT) and Chief Business Officer at Bioxell S.p.A, which was acquired by Cosmo Pharmaceuticals S.A. He began his career at SmithKline Beecham Pharmaceuticals before joining Novartis as Vice President, Global Business Development & Licensing. Prior to Realm, Mr. Martin served as President at moksha8 Pharmaceuticals Inc., a leading Latin American specialty pharmaceutical company. Mr. Martin holds a BA from Cornell University and an MBA from Harvard.
Chief Financial Officer and Chief Operating Officer
Executive Director, Company Secretary
Marella Thorell was appointed Chief Financial Officer and Executive Director in March 2013 and was appointed Chief Operating Officer in October 2014. Previously, she was a key member of the Realm Therapeutics senior leadership team, and has been Company Secretary since October 2011. She offers more than 25 years of experience in finance, operations, and human resources. Previously, she was the President of Thorell Consulting, a business consulting firm. Ms. Thorell worked at Campbell Soup Company (NYSE: CPB), where she held a number of financial and management roles. She began her career and earned her CPA accounting qualification with Ernst & Young LLP. Ms. Thorell holds a BS in Business from Lehigh University.
Christian Peters, MD, PhD
Chief Medical Officer
Dr. Christian Peters Realm Therapeutics in April 2016 as the Chief Medical Officer (CMO). He has over 25 years’ experience, including 15 years of successful clinical development and commercialization in a number of senior leadership positions in the pharmaceutical industry, and more than 10 years of clinical and research experience in academic settings. Prior to Realm, Dr. Peters served as CMO of Therakos. He oversaw corporate strategy and execution for Global Clinical Development, Regulatory Affairs, Pharmacoeconomics and Medical/Scientific Affairs. He previously held a number of senior positions at CSL Behring, and its predecessor Aventis Behring LLC, and at Therakos, then owned by Johnson & Johnson. He received his M.D. and Ph.D. in cellular immunology from the Free University Berlin Medical School in Germany
Vice President, Business Development & Strategy
Cary Schockemoehl joined Realm Therapeutics in 2013 as Director of Marketing for Health Sciences, added Product Development in 2014, became Sr. Director Product Development and Strategy in 2015, and VP of Business Development in 2016. She brings more than 15 years of experience in positions of increasing leadership in sales, marketing, brand management, product development, business development and strategy. Most recently, she spent eight years at Synthes (DePuy-Synthes Companies of Johnson & Johnson) where she developed and managed global strategic marketing and product programs. She started her career at Abbott Laboratories in the diabetes division. Ms. Schockemoehl holds a BS from James Madison University and an MBA from Northeastern University.